WISE Receives FDA Clearance for its WISE Cortical Strip Bringing Neuromonitoring to the Next Level
View the full release here: https://www.businesswire.com/news/home/20221201005070/en/
- View the full release here: https://www.businesswire.com/news/home/20221201005070/en/
The WISE Cortical Strip is the first product receiving FDA clearance within the Companys WISEneuro Monitoring product family. - The FDA clearance follows the CE mark already received by the product in May 2021.
- The WISE Cortical Strip performances have been successfully validated in a multicentric pre-market clinical study in Europe, the WIN study ( NCT03731455 ), that demonstrated safety, performance and usability of the product.
- As a result, the WISE Cortical Strip is highly ergonomic and conformable to the brain surface.